Digital Epigenetic Mapping Service
Digital Epigenetic Mapping Service is a biotechnology and data analytics offering that maps and interprets epigenetic modifications using computational models, translating biological signals into actionable insights for healthcare, research, and precision medicine. It integrates genomic data, AI, and cloud infrastructure to track gene expression changes influenced environment and lifestyle factors.

The Rise of Digital Epigenetic Mapping as a Commercial Force in Europe
The post-genomic era has ushered in a new understanding of biology, shifting focus from the static blueprint of the genome to the responsive layer of the epigenome. This regulatory layer, comprising mechanisms like DNA methylation, histone modifications, and non-coding RNAs, acts as the software that runs the genetic hardware.

In your experience as a managing director at Eurofins, what would you say are some of the recent changes you witnessed regarding the implementation and use of technology?
The core of my work is linked to the world of cell and gene therapies. It is that part of life sciences where innovation is important and is something that the industry is proactively looking for. Cell and gene therapies are innovative medicine, as they can provide life-changing solutions and ultimately be a physician's weapon. However, there is currently no clear model for those.
